Florian Kuehn1, Ernst Klar1, Anja Bliemeister1, Michael Linnebacher1. 1. Florian Kuehn, Ernst Klar, Anja Bliemeister, Michael Linnebacher, Department of General, Thoracic, Vascular and Transplantation Surgery, Molecular Oncology and Immunotherapy, University of Rostock, 18057 Rostock, Germany.
Abstract
AIM: To analyze the cellular immune response towards microsatellite-instability (MSI)-induced frameshift-peptides (FSPs) in patients suffering from inflammatory bowel disease (IBD) with and without thiopurine-based immunosuppressive treatment. METHODS: Frequencies of peripheral blood T cell responses of IBD patients (n = 75) against FSPs derived from 14 microsatellite-containing candidate genes were quantified by interferon-γ enzyme-linked immunospot. T cells derived from 20 healthy individuals served as controls. RESULTS: Significant T cell reactivities against MSI-induced FSPs were observed in 59 of 75 IBD patients (78.7%). This was significantly more as we could observe in 20 healthy controls (P = 0.001). Overall, the reactivity was significantly influenced by thiopurine treatment (P = 0.032) and duration of disease (P = 0.002) but not by duration or cumulative amount of thiopurine therapy (P = 0.476). Unexpected, 15 of 24 (62.5%) IBD patients without prior thiopurine treatment also showed increased FSP-specific immune responses (P = 0.001). CONCLUSION: These findings propose FSPs as potential novel class of inflammation-associated antigens and this in turn may have implications for screening, diagnosis as well as clinical management of patients suffering from IBD and other inflammatory conditions.
AIM: To analyze the cellular immune response towards microsatellite-instability (MSI)-induced frameshift-peptides (FSPs) in patients suffering from inflammatory bowel disease (IBD) with and without thiopurine-based immunosuppressive treatment. METHODS: Frequencies of peripheral blood T cell responses of IBDpatients (n = 75) against FSPs derived from 14 microsatellite-containing candidate genes were quantified by interferon-γ enzyme-linked immunospot. T cells derived from 20 healthy individuals served as controls. RESULTS: Significant T cell reactivities against MSI-induced FSPs were observed in 59 of 75 IBDpatients (78.7%). This was significantly more as we could observe in 20 healthy controls (P = 0.001). Overall, the reactivity was significantly influenced by thiopurine treatment (P = 0.032) and duration of disease (P = 0.002) but not by duration or cumulative amount of thiopurine therapy (P = 0.476). Unexpected, 15 of 24 (62.5%) IBDpatients without prior thiopurine treatment also showed increased FSP-specific immune responses (P = 0.001). CONCLUSION: These findings propose FSPs as potential novel class of inflammation-associated antigens and this in turn may have implications for screening, diagnosis as well as clinical management of patients suffering from IBD and other inflammatory conditions.
Authors: I Saeterdal; J Bjørheim; K Lislerud; M K Gjertsen; I K Bukholm; O C Olsen; J M Nesland; J A Eriksen; M Møller; A Lindblom; G Gaudernack Journal: Proc Natl Acad Sci U S A Date: 2001-10-30 Impact factor: 11.205
Authors: Sang-Heon Lee; Dong Kyung Chang; Ajay Goel; C Richard Boland; William Bugbee; David L Boyle; Gary S Firestein Journal: J Immunol Date: 2003-02-15 Impact factor: 5.422
Authors: Christina L Chang; Giancarlo Marra; Dharam P Chauhan; Hannah T Ha; Dong K Chang; Luigi Ricciardiello; Ann Randolph; John M Carethers; C Richard Boland Journal: Am J Physiol Cell Physiol Date: 2002-07 Impact factor: 4.249
Authors: Eva Ripberger; Michael Linnebacher; Yvette Schwitalle; Johannes Gebert; Magnus von Knebel Doeberitz Journal: J Clin Immunol Date: 2003-09 Impact factor: 8.317
Authors: T A Brentnall; R Chen; J G Lee; M B Kimmey; M P Bronner; R C Haggitt; K V Kowdley; L M Hecker; D R Byrd Journal: Cancer Res Date: 1995-10-01 Impact factor: 12.701
Authors: R Parsons; G M Li; M Longley; P Modrich; B Liu; T Berk; S R Hamilton; K W Kinzler; B Vogelstein Journal: Science Date: 1995-05-05 Impact factor: 47.728